policy+practice

Critics of a proposed rule to import drugs from Canada cite safety concerns and other potential problems.

Fraud is always a problem when it comes to big government spending, but what about the $2 trillion coronavirus emergency relief plan?

COVID-19 response for Pharma companies.

Chimeric Antigen Receptor (CAR) T-cell therapy is a relatively new and powerful cancer treatment that greatly benefits patients, including the Medicare population.

Statement by Ursula von der Leyen, President of the European Commission, calling on drug industry to re-organize supply chain and production lines.

Britain’s antitrust watchdog said it has suspended two investigations into pharmaceutical companies that it suspects of illegally colluding on the price of drugs.

The companies have a combined total of 203 alleged violations for price gouging and face fines ranging from $12,000 to $69,500.

A new study suggests that the cost of the medication has dissuaded people from filling prescriptions.

The move, which will also reset copay cards to the same monthly $35 level, comes amid ongoing angst over the cost of the diabetes treatment.

The concern about the dependency of the US supply chain on nations such as China has been known about for some time.

Drugmaker Eli Lilly said it has capped the out-of-pocket cost for insulin to $35 per month to help diabetes patients across the U.S.

President Donald Trump says that he will look at putting a hold on the U.S. contribution to the World Health Organization, claiming they "really blew it".

The Cancer Research UK (CRUK) funds nearly half of the cancer research in the country.

Operational considerations for 2020

Intellectual property (IP) — patent, copyright, trademark and industrial design — is the foundation for a thriving consumer society and a significant driver for economic growth.